Amwill Health Care IPO subscription started on Wednesday, February 5, 2025, and will close on Friday, February 7, 2025, as per the schedule. The price band is set at ₹105 to ₹111 per share with a face value of ₹10.
Amwill Health Care IPO Subscription Status
Amwill Health Care IPO Subscribed over 5.66x on its Last day till 05.00 PM on 7th February 2025.
- Amwill Health Care IPO subscription QIB investors portion is 7.8x times, while NII subscribed 5.65x times and RII investors subscribed 4.61x times.
- The company has received bids for 2,90,58,000 shares against 51,32,400 shares on offer on the Last day.
- Amwill Health Care IPO Subscribed over 1.42x on day 2.
- Amwill Health Care IPO Subscribed over 1.04x on day 1.
About Amwill Health Care IPO
Involved in the market of derma-cosmetics development since 2009, Amwill Health Care is one of the leading companies that focuses on the development of derma-cosmetics products by partnering up with manufacturers, distributors, and third-party product development agencies. The company mainly focuses on the development of dermatological, cosmeceutical, and aesthetical skin care products that suit a wide range of skin types. They formulate their products by keeping purity and using high-quality ingredients hoping to solve all the concerns of their clients focusing on establishing themselves as one-stop solutions for skincare. Their goal is to provide a comprehensive range of skincare that delivers its indented result of curing, healing, and protecting the skin. Amwill Health Care recently formulated 7 new products in their skin care line including Proputor Tabs, XL Hydra Cream, Ozederm Cream, PD-Pill 10 Tablets, XL Aqua Moisturizing Lotion, Ultra Kromaglo Effervescent Tablets, and Depimed Ultra Cream. With establishing a strong presence in Karnataka, Andhra Pradesh, and Telangana, it will continue to expand its business.
Amwill Health Care IPO Company Financial Report
The company reported revenue of ₹44.28 crores in 2024 against ₹30.28 a crore in 2023. The company reported a profit of ₹12.54 crores in 2024 against a profit of ₹3.11 crores in 2023.
Amwill Health Care IPO GMP:
Amwill Health Care IPO GMP was ₹7 as of Friday, 7th February 2025. That indicates the IPO is trading at ₹118 with ₹7 premium in the grey market against the issue price of ₹111.
